Picture of Cardax logo

CDXI Cardax Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Cardax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.78-1.99-4.02-5.09-5.06
Depreciation
Amortisation
Non-Cash Items0.2310.2420.741.512.18
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.267-0.3670.0530.0221.05
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.26-2.08-3.2-3.52-1.79
Other Investing Cash Flow Items-0.029-0.019-0.037-0.062-0.015
Sale of Fixed Assets
Change in Net Intangibles
Cash from Investing Activities-0.029-0.019-0.037-0.062-0.015
Financing Cash Flow Items-0.04
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.124.181.243.361.81
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.1652.08-1.99-0.224-0